Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Gavreto
Gavreto
After Roche breakup, Blueprint Medicines finds Gavreto a new home at Rigel
Fierce Pharma
Thu, 02/22/24 - 11:40 am
Rigel Pharmaceuticals
Gavreto
RET inhibitors
Blueprint Medicines
Roche
FDA Grants Regular Approval of Gavreto for Metastatic NSCLC Subset
Cure Today
Wed, 08/9/23 - 10:42 pm
Genentech
Blueprint Medicines
Gavreto
non-small cell lung cancer
Roche pulls a Gavreto approval before Blueprint severance, citing unfeasible trial
Fierce Pharma
Wed, 07/5/23 - 07:12 pm
Roche
Blueprint Medicines
cancer
Gavreto
accelerated approvals
FDA
Roche and Blueprint agree to end collaboration for cancer drug Gavreto
Endpoints
Thu, 02/23/23 - 04:30 pm
Roche
Gavreto
Blueprint Medicines
cancer
Roche, Blueprint raise pressure on Lilly with new Gavreto approval
Pharmaforum
Wed, 12/2/20 - 10:33 am
Roche
Blueprint Medicines
Gavreto
thyroid cancer
Retevmo
Eli Lilly
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
Xconomy
Sun, 09/6/20 - 07:22 pm
Blueprint Medicines
FDA
Gavreto
pralsetinib
cancer
RET
non-small cell lung cancer